Randomized trial compares the effectiveness of Vasa and Kantakari Avaleha in managing Kaphaja Kasa in children, indicating distinct outcomes.
Background: Kaphaja Kasa (productive cough) is a common respiratory ailment in children, often linked to dietary and environmental triggers that vitiate Kapha Dosha. In Ayurveda, Avaleha are preferred for their palatability and sustained action. Aims: This study compares the clinical efficacy of Vasa Avaleha and Kantakari Avaleha in school-aged children (6-16 years). Methods: A randomized comparative clinical trial was conducted with 100 patients divided into Group A (Kantakari Avaleha) and Group B (Vasa Avaleha). Parameters including Total Leukocyte Count (TC), ESR, and cough frequency were assessed over 14 days. Results: Both groups showed significant improvement; however, Group A exhibited a superior reduction in TC levels (Mean Diff: 1045.5 cells/mm³) and a higher percentage of "Good" to "Excellent" clinical outcomes (83.8%) compared to Group B. Conclusion: Kantakari Avaleha is highly effective in managing pediatric Kaphaja Kasa by breaking the pathogenesis (Samprapti Vighatana) through its bronchodilatory and Chedana (expectorant) properties.
No takes yet. Share an insight, caveat, or question.
Dr. Bhargav Mehta*1, Vd. Manchak Kendre2, Dr. Nagesh Gandagi3 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: